The use of stable, isotopically labeled compounds in controlled exposure experiments at environmentally relevant levels allows for the distinguishing of urinary metabolites associated with known exposure from background levels generally present in the urine. Exposures of volunteers to 13 C-benzene for 2 h at 40710 p.p.b. were conducted after obtaining informed consent, and urinary phenol, catechol, hydroquinone and trans,trans-muconic acid were measured. Each isotopically labeled urinary metabolite was determined in the presence of significantly higher concentrations of the unlabeled metabolite. Following exposure, free and acid hydrolyzed phenol, acid hydrolyzed catechol and hydroquinone, and free trans,trans-muconic acid were determined by GC/MS. The percentage of trans,trans-muconic acid excreted was higher than reported following exposure at occupational levels. The use of isotopically labeled compounds has the potential to investigate the metabolism of common environmental contaminants for validation of toxicokinetic models and improve risk extrapolation from high concentration occupational exposures and animal studies to environmentally relevant pollutant levels.
Introduction
Extrapolation of adverse health outcomes from epidemiologic or toxicological studies in animals at high doses in which metabolites are the biologically active agents to low-level environmental exposures assumes that the metabolic profiles are the same or that differences can be accounted for in the risk assessment. Measurements of metabolites in urine or blood following individual low-level exposure to assess the amount of individual metabolites formed are not only analytically challenging due to potential contamination and the required sensitivity, but may also not be possible because of the presence of the metabolites from general, uncontrolled environmental exposures to the agent of interest or because the metabolites may be endogenously present or are also common to other environmental agents. Being able to distinguish the metabolites resulting from a specific known exposure from background levels in the body would permit the determination of the metabolic profile. One approach to distinguish metabolites produced from low-level, known exposures to common environmental pollutants from the background levels in urine is to use stable isotopically labeled compounds during the exposure (Nihle´n et al., 1999) . One compound amenable to this approach is benzene, since it produces a series of urinary metabolites that includes: phenol, catechol, hydroquinone and trans,trans-muconic acid, which are commonly excreted in the urine at low concentrations.
Benzene is a well-studied toxicant, but the complete metabolic profile in humans following environmental exposure has not been definitely determined because of the background levels of many of the metabolites in the general population. Qualitatively, the same metabolites are excreted by animals exposed to benzene and humans following occupational exposures (Inoue et al., 1986 (Inoue et al., , 1988 (Inoue et al., , 1989a Sabourin et al., 1988 Sabourin et al., , 1992 Boogaard and van Sittert 1996; Rothman et al., 1997; Lovern et al., 2001) . Benzene is a ubiquitous environmental toxicant (Wallace, 1990) with known adverse health outcomes, particularly related to blood disorders and acute myelogenous leukemia (as reviewed by Snyder and Kalf, 1994 ; Gist and Burg, 1997; Goldstein and Witz, 2000) . Benzene has two major metabolic pathways, one leading to ring hydroxylation and the other to ring opening (Medeiros et al., 1997) . In laboratory animals and following occupational exposures at p.p.m. concentrations, benzene is metabolized via the ring hydroxylation pathway to a series of oxygenated ring structures with phenol, catechol, hydroquinone, benzene triol and Sphenylmercapturic acid being stable metabolites that have been measured in the urine (Inoue et al., 1986 (Inoue et al., , 1988 (Inoue et al., , 1989a Van Sittert et al., 1993; Popp et al., 1994) . Ring opening metabolism leads to trans,trans-muconic acid and 6-hydroxy-trans,trans-2,4-hexadienoic acid, which are excreted in the urine and shown to be derived from trans,transmuconaldehyde (Witz et al., 1985; Sabourin et al., 1988; Inoue et al., 1989a, b; Bechtold et al., 1991; Ducos et al., 1992; Kline et al., 1993) . The use of radiolabeled isotopes has been the main tool in examining benzene metabolism in animals since it provides high sensitivity and specificity for tracing the metabolites excreted and their distribution in various tissues and organs in the body (Parke and Williams, 1953) . Stable isotope analysis has had limited use in humans as markers of the sources of exposure and for evaluating metabolism for environmental exposures. Lead isotopic signatures have been used to trace the source of lead exposures, particularly when the lead has been mobilized from storage sites within the body, such as the bones, due to changes in weight or during pregnancy (Rabinowitz, 1991) . Stable isotopes of minerals have been used to examine mineral bioavailability and metabolism (Turnlund, 1989) . Stable isotopes contained in compounds have been used as probes of metabolic activity of specific enzyme systems. Labeled ( 13 C) carbon dioxide expired following ingested ( 13 C) caffeine has been used to determine the activity of the P4502A1 enzyme system (Lambert et al., 1990) . Induction of the P4502A1 enzyme system may be indicative of previous exposures to a variety of environmental agents, such as dioxin, PCBs, PBBs and chlorinated pesticides (Brambilla et al., 1995; Fitzgerald et al., 1996) . Studies on direct exposure to stable isotopes at p.p.m. levels and metabolism have been reported. Deuterated labeled toluene in blood and breath was compared with unlabeled toluene in a pharmacokinetic study and no differences were observed (Morgan et al., 1993) . Isotopically labeled methyl tertiary butyl ether (MTBE) has been used in controlled human studies combined with 13C NMR to characterize a variety of MTBE metabolites that were not previously observed in humans (Nihle´n et al., 1999) . Measuring the amount of each metabolite produced following low-level, environmental exposures has proven difficult for benzene. Attempts to document different benzene metabolites (e.g. phenol, catechol, hydroquinone and trans,trans-muconic acid) as biomarkers at the lower end of exposure in occupational settings and for environmental exposures have had only limited success, such as identifying group differences without documenting a clear exposure-excretion relation for individuals, because of the presence of these metabolites in urine as a result of either undocumented benzene exposures or contributions from nonbenzene sources (Inoue et al., 1988 (Inoue et al., , 1989b Balikova and Kohlicek, 1989; Yu and Weisel, 1996b; Medeiros et al., 1997; Scherer et al., 1998; Pezzagno et al., 1999) . Recent studies have suggested that S-phenyl mercapturic acid may be a metabolite specific to benzene, although it represents only a small portion, that is, o2%, of the total benzene dose (Mueller et al., 1987; Popp et al., 1994; Boogaard and van Sittert, 1996; Medeiros et al., 1997) . Radiolabeled benzene is often used in animal studies linking benzene metabolites with the benzene dose to provide sensitivity and specificity. Current capability of gas chromatography/mass spectrometry makes it possible to evaluate the metabolites at low-level human exposures using stable isotope ( 13 C) labeled benzene, to provide fundamental information on metabolism and toxicokinetics in humans.
Documenting the profile of benzene metabolites following low-level human exposures is potentially useful in assessing relative risk. It is still unclear which metabolite or combination of metabolites as well as the relative amount(s) is responsible for initiating or promoting the pathway leading to the adverse health affects associated with benzene (as reviewed by Snyder et al., 1993; Snyder and Kalf, 1994; Medinsky et al., 1995; Goldstein and Witz, 2000) . Combinations of metabolites, such as hydroquinone and phenol, were shown to cause hematotoxic effects similar to those of benzene, suggesting that a single metabolite is not responsible. Owing to synergistic effects between hydroxylated benzene metabolites in their further activation to reactive intermediates, the relative amounts in the target tissue may also be of importance in the progression to a hematological disease (Eastmond et al., 1987) . Trans,trans-muconaldehyde is a biologically active compound that is toxic to bone marrow in a manner similar to benzene (Witz et al., 1996) . A simple extrapolation of the toxicological data in animals or high-level human exposure to low-level exposure in humans assumes that the benzene metabolites responsible for adverse effects are produced in similar relative amounts at all doses. While each of the key metabolites discussed above has been identified in animals and humans at a variety of doses, the relative amounts of each formed have been found to vary with dose and species Sabourin et al., 1989 Sabourin et al., , 1990 Weisel et al., 1996; Yu and Weisel, 1996b; Mathews et al., 1998) . If the proportion of the metabolites produced by each pathway is a determining factor in causing the adverse effect, it is important to determine the amounts of metabolites formed by each pathway at levels that are relevant to the exposure being considered.
This paper documents the utilization of 13 C-labeled benzene during a controlled low-level exposure (40 p.p.b. for 2 h) of volunteers to determine the amounts of various metabolites excreted and generate toxicokinetic data that can be used for evaluating physiologically based toxicokinetic models for improved risk estimations. The methodology can also be used to examine whether metabolism is affected by specific polymorphisms that would suggest gene-environmental linkages and differential susceptibility among individuals. This approach should be useful for other toxicants whose metabolites may be difficult to be uniquely associated with a particular environmental exposure due to the presence of background contributions to those metabolites. Benzene is also expired in breath following exposure. Breath analysis could be used to establish the portion of the benzene exposure that was not metabolized.
Materials and methods

Benzene Exposures
Exposure and biological sampling protocols were reviewed and approved by the Institutional Review Board of Robert Wood Johnson Medical School-University of Medicine and Dentistry of New Jersey. Written informed consent was obtained from each participant prior to the enrollment in the study and after each subject was provided with details about potential toxicity of benzene and a comparison of the benzene dose being used in the exposure compared to that encountered in the environment. Each participant received a medical examination to confirm that he/she was in general good health prior to the exposure. General characteristics of the participants are provided in Table 1 .
The benzene exposures were conducted in the Controlled Environmental Facility ( (Chan et al., 1993) . Thus, the controlled exposures were within the upper end of the concentrations that have been encountered while commuting within major metropolitan regions. The exposure concentration used was less than one-twentieth of the air concentration allowed during occupational exposures up to 8 h daily, 5 days a week of 1 p.p.m. (http://www.osha-slc.gov/SLTC/benzene/) and less than one-tenth of the American Conference of Governmental Industrial Hygiene adapted value of 0.5 p.p.m. for a time weighted 8 h average and well below the 2.5 p.p.m. for the Short-term Exposure Limit (ACGIH, 1998). Isotopically ( 13 C) labeled benzene (Cambridge Isotopes Laboratories, Inc., 99% labeled on all six carbons) was continuously introduced into a heated glass flask at a constant flow rate using a syringe pump (Sage Instruments). The benzene was evaporated completely in the heated flask and the vapors were transferred into the intake air of the CEF through a heated transfer line by flushing the flask with air purified through a charcoal filter. The syringe was operated at a flow rate of 2 ml/min. The CEF operates in a single air pass through mode, so no air is recirculated back into the CEF. The ventilation rate was set to 8.5 m 3 per min. The intake air was passed through a series of activated carbon filters to remove background volatile organic compounds and HEPA filters to remove particles. The air temperature of the CEF was adjusted to 241C and the relative humidity (RH) to 45%. The benzene was introduced into the CEF and the air concentration was allowed to stabilize at 40710 p.p.b. for at least 15 min prior to the participant entering the CEF. The benzene concentration was continuously monitored using a total hydrocarbon (THC) analyzer (Teledyne Analytical Instruments Model 402R) calibrated with benzene to assure that the levels remained at their target values for the duration of the exposure. If the THC concentration increased above 50 p.p.b., the syringe injection rate was decreased or the exposure session was aborted.
Sample Collection
Urine samples were collected from each participant into new, individual plastic containers prior to and at approximately 3 h time intervals after the exposure while the participant was awake. The first morning void on the following day was also collected. The urine was kept in an ice chest on blue ice until it was taken to the laboratory. Once received, the total volume of each void was determined and a portion of the urine was stored at À401C until analysis.
Sample Analysis
Commercially available derivatizing agents for aromatic alcohols, bis(trimethylsilyl)triflouroacetamide (BSTFA) (Bellefonte, Supelco Park, PA, USA), or carboxylic acids, N-methyl-N-trimethylsilyltrifluoroacetamide+1% trimethlchorosilane (MSTFA/TMCS) (Pierce Biotechnology Inc., Rockville, IL, USA) were used. To determine the ring hydroxylated metabolites phenol, catechol and hydroquinone, 5 ml of urine were transferred to a reaction vial and washed twice with 2 ml of diethyl ether, which was subsequently discarded. The pH of the urine layer was adjusted to o1 by adding hydrochloric acid, followed by the addition of 1 g of sodium sulfate and 5 ml of a 100 p.p.m. methanolic solution of 2,4,6-trichlorophenol were added as an internal standard to correct for variablility in the volume of the ether extracts. Evaluation of the urine samples for 2,4,6-trichlorophenol showed that it was present in about one-third of the samples at less than 10% of the amount added. Thus, endogenous 2,4,6-trichlorophenel did not present an interferent in its use as an internal standard. Other potential internal standards that are not present in any urine sample are 3,5-diflourobenzine and 1,3-benzenediol. The urine was extracted first with 3 ml and then with 2 ml of ether. The ether extracts, which contain the free metabolites, were combined. The ether-water interface was not transferred to avoid any water being present in the extract since water interferes with the derivatizing agent. Deuterated compounds of the metabolites were not used as an internal standards since they have the same mass ions as the 13 C metabolites produced from the isotopically labeled benzene exposures. The metabolites were derivatized by blowing off the ether, adding 150 ml of acetonitrile and 50 ml of BSTFA and heating for 1 h at 851C. A 200 ml aliquot was transferred to an autosampling vial with 1 ml injected into a GC(HP6890)/MSD(5973) operated in the SIM mode for the major ions of the labeled or unlabeled trimethylsilyl derivatives of the ring hydroxylated metabolites (Table 2 ). For determination of trans,-trans-muconic acid, 5 ml of urine were washed, pH-adjusted, and extracted as described above for the hydroxylated benzene metabolites. The ether extracts, which contain free metabolite, were combined and 5 ml of a 100 p.p.m. 2-bromohexanoic acid added as an internal standard. The metabolites in the ether were derivatized with 150 ml of MSTFA/TMCS heated at 801C for 30 min. A 200 ml aliquot was transferred to an autosampling vial with 1 ml injected into a GC(HP6890)/MSD(5973) operated in the SIM mode ( Table 2) .
The metabolite concentrations were determined from the average response of at least five calibration standards prepared from nonlabeled metabolites (0.1 ng, which was near the instrumental detection limit, to 200 ng) to the internal standard. This concentration range spanned the expected sample concentration range. The response of the trimethylsilyl derivative of deuterated phenol and nonlabeled phenol under the GC/MSD conditions used was the same indicating that there was no response difference because of the difference in molecular weight of these compounds. The urine layers obtained after ether extraction of the ring hydroxylated and ring opened products were heated for 1 h at 901C to acid-hydrolyze any conjugated metabolites. The urine samples were then re-extracted with ether, derivatized and analyzed as described above for the free metabolites in order to determine the amount of conjugated metabolites for each of the enzymatic pathways.
Results
During the blow-down process, it was determined that it was necessary to evaporate the ether very slowly to avoid depositing the metabolites on the walls of the test tube where they would not contact the derivatizing solution adequately. If this was not done, low and variable recoveries occurred. When the ether was removed carefully, the average recovery from duplicate analyses of the ring hydroxylated species were 88%, 98% and 109%, for phenol, catechol and hydroquinone, respectively. The recoveries were calculated by comparing the peak areas from standards spiked in water and processed to peak areas obtained by direct derivatization of the compounds. The direct derivatization was accomplished by placing a few microliters of the standard at the bottom of a reactions tube, allowing the solvent to evaporate and directly adding the derivatizing agent to the standard.
Isotopically labeled phenol, catechol, hydroquinone and trans,trans-muconic acid were present in the urine samples following exposure but were not present in the pre-exposure samples, while the unlabeled compounds were present in all urine samples (examples shown in Figures 1a-d) . The pair of ion chromatograms for each compound, isotope labeled and nonisotope labeled, are given with the same abundance scale for comparison purposes. The area counts of ion fragments of the unlabeled derivatized metabolites were from one to several orders of magnitude greater than the area counts of the corresponding ion masses fragments of the 13 C-labeled derivatized metabolites. In the scale expanded figure, the peak of the unlabeled compound appears to be spread out, but the peak width at half the peak height is o0.1 min. Some tailing of the peak for the unlabeled metabolites probably is due to its relatively high concentration. Thus, the large amount of background urinary benzene metabolites in the urine would have made it impossible to identify the contribution of the benzene from the CEF exposure if unlabeled benzene had been used.
The extraction efficiency of phenol was determined by comparing the amount of phenol derivatives extracted from spiked water and urine sample to the response of standards of the derivative prepared from commercially purchased phenoxytrimethylsilane (Aldrich, Milwaukee, WI, USA). The extraction efficiency was 7977% based on triplicate analyses of a spiked solution at 5 mg/l. The extraction efficiency of the other benzene metabolites was not directly determined, since the derivatized form of the metabolites was not commercially available. The extraction efficiency and reproducibility were assessed by comparison of the response of derivatized compounds extracted from water and urine to that obtained by directly reacting small volumes of standards of the metabolites with the derivatizing agent, as described above. Based on these analyses, these extraction efficiency were 86%, 88%, 98% and 109%, for trans, trans muconic acid, phenol, catechol and hydroquinone, respectively. No mathematical adjustment was made for the extraction efficiency, rather standard calibration curves were prepared by adding known amounts of each metabolite to either water or a mixture of 1:1 water:urine solution if the concentration of the metabolite was sufficiently low and extracting and derivatizing the standards following the same procedures as the samples.
The amount of each metabolite excreted by the four subjects is shown in Table 3 . Both free and conjugated phenol, defined as acid hydrolyzed, were present in the urine. Only conjugated catechol and hydroquinone and only free trans,trans-muconic acid were detected in the urine. The dose for an exposure range of 40-50 p.p.b. for 2 h, assuming a breathing rate of 0.6 m 3 /h, for a sedentary individual (USEPA, 1997), and an adsorption across the lungs of 0.64 (Yu and Weisel, 1996a) would be 100-120 mg. The total amount of metabolites excreted calculated as the amount of benzene from which they were formed {mg metabolite excreted Â (molecular weight of benzene/molecular weight of metabolite)} is given in Table 3 . This represents between 40% and 97% of the estimated dose. The remaining benzene could have been excreted as other metabolites or in exhaled breath.
Time series collection of the urine voids was evaluated to assess the time required for each metabolite to be excreted (Figure 2) . The metabolites were present in the first urine void after exposure, within an hour of the end of the 2-h exposure. The maximum amount was excreted about 4 h after the exposure ended, or 6 h after the start of the exposure, and significant amounts were still present in the urine about 3 h later. Some phenol and trans,trans-muconic acid were still present in the following day's urine, although this was usually less than 15% of the total amount excreted. Catechol and hydroquinone were not detected in the urine on the day after exposure. No differences were observed in the temporal excretion pattern of the free and acid hydrolyzed fractions of phenol nor among the four urinary metabolites measured.
Discussion
The use of isotopically labeled benzene in low-level controlled exposures allowed distinguishing the urinary benzene metabolites phenol, catechol, hydroquinone and trans, transmuconic acid associated with environmentally relevant exposures from background levels and the determination of the proportion metabolized by each of the two major pathways.
Previously, human studies found that urinary phenol and other urinary ring hydroxylated benzene metabolites could not be ascribed to benzene exposure below 10 p.p.m. because of other sources of these compounds in urine (Inoue et al., 1986 (Inoue et al., , 1988 . Trans,trans-muconic acid levels in individual voids have been clearly associated with benzene exposures following ppm exposures (Inoue et al., 1989 Figure 1 . Selective ion chromatograms (gas chromatograms monitored at a single mass ion fragment) for the major ion fragments before exposure for the unlabeled (top) and isotopically labeled (second from top) peaks and after exposure for the unlabeled (second from bottom) and labeled (bottom) peaks. The time scale was expanded to display the retention times of each derivatized urinary metabolite confirmed by analyses of pure standard prepared from unlabeled compound and a match of ion fragment ratios. (a) Phenol, (b) catechol, (c) hydroquinone, and (d) trans,transmuconic acid.
opened metabolites as benzene biomarkers following environmental benzene exposures (Yu and Weisel, 1996b) . The percentage of the benzene dose excreted as urinary trans,trans-muconic acid following the exposures was several times greater (Table 3 ) than the 2% reported for occupational exposures of 7-500 p.p.m. h (Inoue et al., 1989) . The percentage of benzene metabolized to urinary trans,trans-muconic acid and the amount of individual hydroxylated metabolites excreted varied across the four individuals studied. These differences may represent differences in the enzyme activity levels responsible for the two different enzyme pathways. Animal studies have found that the amount of benzene excreted as trans,transmuconic acid varies between species and between strains within a single species Valentine et al., 1996; Henderson, 1997) . Genetic variability and exposure to a variety of environmental agents exist for humans and a varied diet can affect metabolic capability. Interindividual variability in benzene metabolism to trans,trans-muconic acid was reported in an occupationally exposed cohort of bus drivers in Italy where a bimodal distribution of trans,trans-muconic acid normalized to creatinine was observed, while the urinary benzene levels, proposed as marker of recent benzene exposure, had a single mode. Both urinary trans,transmuconic acid normalized to creatinine and the ratio of trans,trans-muconic acid to urinary benzene were statistically significantly different for the two groups as defined by the bimodal distribution of trans,trans-muconic acid (Gobba et al., 1997) . Gobba et al. (1997) suggested that the difference was related to the ability of the individuals to metabolize benzene to trans,trans-muconic acid. Genetic polymorphisms exist in the cytochrome-P4502E1 enzyme system that metabolizes benzene, although no evidence of differential benzene metabolism for groups separated on the basis of polymorphisms was identified for a second cohort of Italian bus drivers based on the excretion of trans, trans-muconic acid (Rossi et al., 1999) . Rossi et al. (1999) found polymorphisms in NQOR, CYP2D6 and GSTT1, that is, enzymes involved in detoxification pathways of toxicants as well as in modulating the metabolism pathway of benzene, to be statistically related to variations in benzene metabolism-based urinary trans,trans-muconic acid levels. Other factors besides polymorphisms can affect benzene metabolism. The metabolic rates can change because of coexposure to other agents metabolized by the same enzyme system and induction of enzyme systems can occur from exposures to environmental and dietary agents, such as alcohol and acetone (as reviewed by Lovern et al., 2001) . In contrast to the human studies that did not identify polymophisms in the CYP2E1 directly affecting benzene metabolism, the role of the CYP2E1 enzyme system in the metabolism of benzene to phenol, the initial metabolite in the ring hydroxylation metabolic pathway, has been confirmed in animal studies comparing benzene metabolism in transgenic CYP2E1 knockout mice with wild-type mice (Valentine et al., 1996) . A significant reduction in the total and individual metabolites occurred in the transgenic mice compared to the wild type exposed to 200 p.p.m. benzene by nose-only inhalation for 6 h, while severe benzene-induced cytotoxicity was observed in the wild type but not in the transgenic mice. Acid and enzymatic hydrolysis have been used to assess the amount of the urinary metabolites that were conjugated following occupational exposures (Inoue et al., 1986 (Inoue et al., , 1988 Ong et al., 1988; ). In the current study, both free and conjugated phenol, based on acid hydrolyzation, were observed, while only free trans, trans-muconic acid and conjugated hydroquinone and catechol were measured following the low exposures. Phenol, hydroquinone and catechol have been reported excreted primarily as sulfate and glucuronide conjugates, which are released by acid hydrolysis Valentine et al., 1996; Medeiros et al., 1997) , while free trans,trans-muconic acid is the common form of this metabolite previously reported (Bechtold et al., 1991) . The predominance of conjugated hydroquinone and catechol and only free trans,trans-muconic acid measured here agrees with previously reported analyses following occupational studies. However, approximately equal amounts of free and acid-hydrolyzed phenol were measured, while only limited amounts of free phenol have been reported previously in animals or at occupational exposure levels in humans.
The use of the stable isotopes was critical in determining the temporal variability of these metabolites in the presence of background levels in the body. The clearance rate of these metabolites following the exposures at environmental levels were shorter than those reported for occupational exposure (Qu et al., 2000) and in animals (Sabourin et al., , 1992 . The longer clearance time for occupational exposures could reflect the greater storage of benzene or its metabolites in adipose tissue resulting from the higher concentrations present in the body associated with the longer exposures at greater concentrations as well as the repetitive exposures that occur in occupational settings. Repetitive p.p.m. concentration exposures result in elevated levels of benzene and other volatile air compounds in exhaled breath and blood both at the end of work shifts and the following morning, with lower levels in breath and blood present after several days away from work. Pharmacokinetic models of benzene also predict this type of behavior Bois and Paxman, 1992) . The continued benzene body burden is a result of benzene penetration into and storage in adipose tissue from which it is cleared from the body slowly. The relatively short clearance rate following short duration (minutes to hours) exposures at tens of p.p.b. concentrations observed in this study suggests that the potential dose to different tissues or organs in the body is much more limited following a typical environmental exposure than after occupational exposures. This differential in clearance rate between high and low exposures should be considered in risk calculations.
Conclusions
The use of stable isotopically labeled compounds in controlled exposure experiments at concentrations that normally occur in the environment provides the opportunity to measure urinary metabolites that are present because of background exposures or exposure to multiple sources. Thus, important information on the metabolism can be obtained that would be unavailable following similar magnitude exposures with unlabeled compounds. Differences in the percent of benzene metabolized by the two metabolite pathways were identified at levels lower than reported for occupational studies, with the amount of benzene metabolism to trans,trans muconic acid being greater at environmental levels, replicating the trends found in animals. The urinary clearance of the metabolites was considerably shorter for the low exposure levels compared to that previously reported in occupational settings. These factors need to be considered in the dose extrapolation when estimating risk to benzene exposure within the environment.
